...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZEN003694 Trial Locations
Reply New Message
Back To Forum List View

Six locations are listed for the ZEN003694 Metastatic Castration-Resistant Prostate Cancer trial. So far only OHSU in Portland is recruiting.

University of California San Francisco Medical Center, San Francisco, California

Karmanos Cancer Institute, Detroit, Michigan

Memorial Sloan Kettering Cancer Center, New York, New York

Oregon Health & Science University, Portland, Oregon

Virginia Oncology Associates, Hampton, Virginia

Virginia Oncology Associates, Norfolk, Virginia

4 Recommendations
Icon president Re: ZEN003694 Trial Locations
4
SanFrancisco99
Apr 15, 2016 05:43PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply